Childhood Blood Cancer Types and Programs

The Hematologic Malignancy Center at Dana-Farber/Boston Children's Cancer and Blood Disorders Center features four world-class treatment programs offering patients deep expertise and advanced therapies for specific conditions. Each program features an authority in his/her area of expertise as well as teams of subspecialists and nurses with training and years of proven experience.

Blood cancers affect the production and function of your child's blood cells. While normal blood cells will reproduce and die, cancerous blood cells don't die and instead continually reproduce and crowd out the healthy blood cells. Leukemias and lymphomas are the most common types of cancer in children. Histiocytosis is generally not considered a blood cancer, but it is treated with therapies similar to those used to treat blood cancers.

New Patient Appointments
617-632-5508
Make Appointment Online

We treat every type of blood cancer, even the most rare sub-types.
Leukemia Treatment Program
Dana-Farber/Boston Children's is home to one of the top leukemia treatment programs in the world. Our program has played a leading role in refining treatment for childhood leukemia, resulting in cure rates of more than 90 percent for acute lymphoblastic leukemia (ALL). We continue to lead clinical trials designed to increase cure rates while decreasing treatment-related side effects.

Acute Lymphoblastic Leukemia (ALL)

Relapsed Acute Lymphoblastic Leukemia (ALL)

Acute Myeloid Leukemia (AML)

Chronic Myeloid Leukemia (CML)

Juvenile Myelomonocytic Leukemia (JMML)

Lymphoma Treatment Program
Specialists in our Lymphoma Program have deep experience in diagnosing and treating a wide range of newly diagnosed and relapsed lymphomas. Our clinical research program offers unique access to clinical trials in which children can receive the newest lymphoma treatments.

Hodgkin Lymphoma

Non-Hodgkin Lymphoma

Burkitt Lymphoma

Diffuse Large B-cell Lymphoma

Primary Mediastinal B-cell Lymphoma

Anaplastic Large Cell Lymphoma

Lymphoblastic Lymphoma

Rare Non-Hodgkin Lymphomas

Histiocytosis Treatment Program
Dana-Farber/Boston Children's provides expert treatment for newly diagnosed or recurrent histiocytosis, which is a cancer-like condition and may involve treatment with chemotherapy. We also treat related disorders such as juvenile xanthogranuloma and Rosai Dorfman disease.

Langerhans Cell Histiocytosis

Hemophagocytic Lymphohistiocytosis

Node Assessment Program
Our Node Assessment Program (NAP) provides a multidisciplinary approach to the care of children with persistent swelling of the lymph nodes (or glands), a condition known as lymphadenopathy. Pediatric patients of all ages have access to expert clinicians that include otolaryngologists, surgeons, pathologists, hematologists/oncologists, infectious disease specialists and radiologists.

Childhood Hematologic Malignancy Center

Childhood Blood Cancer Types and Programs

We treat every type of blood cancer, even the most rare sub-types.